Marker Therapeutics, Inc. — Director's Dealing 2021

Dec 9, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Marker Therapeutics, Inc. (MRKR)
CIK: 0001094038
Period of Report: 2021-12-08

Reporting Person: Knobil Katharine (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1500	Indirect

Footnotes

F1: The securities are held by the spouse of the Reporting Person, who shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein.